Rani Therapeutics
Price & Volume
Stats
See more52W Range | $0.55-$2.15 |
Market Cap | $78.1M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $4.8M |
Revenue Growth (YoY) | 893% |
Gross Profit (12 Mos) | $4.8M |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • 2 months ago
Rani Therapeutics to Participate in Upcoming September Conferences
Yahoo Finance • 3 months ago
Wednesday 7/22 Insider Buying Report: CAG, RANI
Yahoo Finance • 4 months ago
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 4 months ago
Rani Therapeutics CFO Svai Sanford Steps Down, Nicholas Maestas Appointed As Successor
About
CEO | Mr. Talat Imran |
Address | 2051 Ringwood Avenue, San Jose, CA, United States, 95131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |